bioRxivCancer BiologyPreprint
LINC01133 knockout increases malignancy by migration mechanisms in Hs578T Triple-Negative Breast Cancer Cells
Henrique César Jesus-Ferreira, Leandro Teodoro JúnioriD, Ana Cláudia Oliveira CarreiraiD, Mari Cleide SogayariD
Abstract
Long non-coding RNAs (lncRNAs) have attracted increasing interest because of their roles as modulators of tumor progression, acting either as oncogenic drivers or tumor suppressors, depending on the cellular context. LINC01133 has been implicated in regulation of multiple tumor-related mechanisms; however, its role in breast cancer, particularly in the triple-negative subtype, remains poorly characterized. In this study, we investigated the impact of LINC01133 depletion on malignant phenotypes and on the expression of migration- and invasion-associated genes using the Hs578T triple-negative breast cancer (TNBC) cell line, through comparative analyses of parental, control, and LINC01133-knockout cell lines, namely Hs578T_wt, Hs578T_ctr, and Hs578T_ko. Functional characterization included morphological analysis, growth assays, anchorage-independent colony formation, migration, invasion, and quantitative biomolecular experiments. Depletion of LINC01133 led to reduction of cell diameter, a significant increase in colony-forming capacity, and marked enhancement of migratory and invasive potential. At the molecular level, LINC01133 loss induced the expression of genes associated with extracellular matrix remodeling and cellular plasticity, including fibronectin, vimentin, integrins, FOXC1, and TWIST1, concomitant with reduced expression of ZEB1, TWIST2, and N-cadherin. Collectively, these data indicate that LINC01133 acts as a potential fine regulator of in vitro migration and invasion processes in TNBC, with its expression favoring a more asymptomatic mode of tumor progression, whereas its loss markedly enhances tumor malignancy.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- lncRNA-WAL Promotes Aggressiveness of Triple-Negative Breast Cancer via inducing β-Catenin nuclear translocation.
Hongyan Huang, Haiyun Jin, … Yan Nie·bioRxiv·Sep 6, 2022
- LRP-1 promotes tumor progression of triple negative breast cancers by coordinating extracellular matrix remodeling and immune cell infiltration
Maxence Mocquery-Corre, Lucille Cartier, … Jessica Thevenard-Devy·bioRxiv·Jul 1, 2026
- Laminin N-terminus α31 is upregulated in invasive ductal breast cancer and changes the mode of tumour invasion.
L. D. Troughton, T. Zech, K. J. Hamill·bioRxiv·May 28, 2020
- Whole transcriptome analysis reveals ELK3 as a key driver of metastasis through regulation of 3D migration and stemness in triple-negative breast cancer cells
Daniel Cruceriu, Loredana Bălăcescu, … Ovidiu Bălăcescu·bioRxiv·Jul 22, 2026
- MaTAR25 LncRNA Regulates the Tensin1 Gene to Impact Breast Cancer Progression
K.-C. Chang, S. D. Diermeier, … D. L. Spector·bioRxiv·Feb 3, 2020
- ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity
Sofia Morazzo, Soraia Fernandes, … Giancarlo Forte·Frontiers in OncologyPeer-reviewed·Aug 27, 2025